Testing effectiveness (Phase 2)Study completedNCT03056755
What this trial is testing
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments
Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 383